Tieteelliset julkaisut (tärkeimmät)

Preclinical evaluation of phenotypic mariAST MRSA RUO test against routine MRSA screening methods in hospital setting. Antikainen P, et al. 28th European Congress of Clinical Microbiology and Infectious Diseases 2019, Amsterdam, Alankomaat. Tieteellinen tiivistelmä #2938 ja posteri #P2615.

mariAST® methodology enables high precision MIC testing. Antikainen P, et al. 36th Annual meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases 2019, Trondheim, Norja. Tieteellinen tiivistelmä ja posteri #P-19, 67782.

mariAST methodology for real-time and rapid phenotypic AST enables species-specific detection directly from clinical samples down to 1 CFU/well. Antikainen P, et al. 27th European Congress of Clinical Microbiology and Infectious Diseases 2017, Wien, Itävalta. Tieteellinen tiivistelmä #4771 ja posteri #P0172.

mariAST® in-well culture methodology for direct, real-time and rapid phenotypic AST enables bacterial detection down to 1 CFU/well. Antikainen P, et al. NSCMID 2016 October, Rovaniemi, Suomi. Tieteellinen tiivistelmä ja posteri #049.

High-throughput screening of colonization samples for methicillin-resistant Staphylococcus aureus. Stenholm T, et al. Scand J Infect Dis. 2013;45:922–9.

Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus. Stenholm T, et al. Eur J Clin Microbiol Infect Dis 2011;30:1237–43.

Development of a rapid assay methodology for antimicrobial susceptibility testing of Staphylococcus aureus. Koskinen JO et al. Diagn Microbiol Infect Dis. 2008;62:306–16.